{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:33Z","timestamp":1786120353591,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/fpc.0b013e32834d8376","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T03:45:00Z","timestamp":1320119100000},"page":"69-72","source":"Crossref","is-referenced-by-count":20,"title":["Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab"],"prefix":"10.1097","volume":"22","author":[{"given":"Barna","family":"Budai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Koml\u00f3si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilmos","family":"Adleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Pap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"R\u00e9ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcnde","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Kralov\u00e1nszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"L\u00e1ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Hitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210213","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2217\/14622416.9.8.1079","article-title":"Pharmacogenetics in colorectal cancer: a systematic review.","volume":"9","author":"Funke","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R2-8-20210213","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jss.2007.04.038","article-title":"Lowering homocysteine decreases levels and expression of VEGF(165) and endostatin.","volume":"146","author":"Atta","year":"2008","journal-title":"J Surg Res"},{"key":"R3-8-20210213","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.bjc.6604673","article-title":"Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.","volume":"99","author":"Rouits","year":"2008","journal-title":"Br J Cancer"},{"key":"R4-8-20210213","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2169\/internalmedicine.47.1122","article-title":"The relationship between vascular endothelial growth factor (VEGF) and microalbuminuria in patients with essential hypertension.","volume":"47","author":"Ayerden Ebinc","year":"2008","journal-title":"Intern Med"},{"key":"R5-8-20210213","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/annonc\/mdn637","article-title":"Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab.","volume":"20","author":"Scartozzi","year":"2009","journal-title":"Ann Oncol"},{"key":"R6-8-20210213","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/1471-2407-10-525","article-title":"SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.","volume":"10","author":"Komlosi","year":"2010","journal-title":"BMC Cancer"},{"key":"R7-8-20210213","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12253-008-9126-9","article-title":"Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells.","volume":"15","author":"Reti","year":"2009","journal-title":"Pathol Oncol Res"},{"issue":"Suppl","key":"R9-8-20210213","first-page":"47","article-title":"Comparison of first-line deGramont, FOLFIRI and bevacizumabFOLFIRI treatments in case of different genotypes of metastatic colorectal cancer patients.","volume":"53","author":"Hitre","year":"2009","journal-title":"Magy Onkol"},{"key":"R10-8-20210213","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00384-010-1108-1","article-title":"Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab.","volume":"26","author":"Formica","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"R11-8-20210213","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/jnci\/djm115","article-title":"UGT1A128 genotype and irinotecan-induced neutropenia: dose matters.","volume":"99","author":"Hoskins","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R12-8-20210213","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GIM.0b013e31818efd77","article-title":"Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan An evidence-based review.","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet Med"},{"key":"R13-8-20210213","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjc.6605776","article-title":"UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy.","volume":"103","author":"Martinez-Balibrea","year":"2010","journal-title":"Br J Cancer"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01213011-201201000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:31:03Z","timestamp":1786048263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-201201000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32834d8376","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}